Abstract
Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8þ) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 30 region of BRCA2 (c.7914þ) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001c.7913 [HR ¼ 1.78; 95% confidence interval (CI), 1.25–2.52; P ¼ 0.001], as well as elevated risk of Gleason 8þ prostate cancer (HR ¼ 3.11; 95% CI, 1.63–5.95; P ¼ 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR ¼ 2.83; 95% CI, 1.71–4.68; P ¼ 0.00004) and elevated risk of Gleason 8þ prostate cancer (HR ¼ 4.95; 95% CI, 2.12–11.54; P ¼ 0.0002). No genotype–phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 624-638 |
| Number of pages | 15 |
| Journal | Cancer Research |
| Volume | 80 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Feb 2020 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cancer Research, Vol. 80, No. 3, 01.02.2020, p. 624-638.
Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
AU - Patel, Vivek L.
AU - Busch, Evan L.
AU - Friebel, Tara M.
AU - Cronin, Angel
AU - Leslie, Goska
AU - McGuffog, Lesley
AU - Adlard, Julian
AU - Agata, Simona
AU - Agnarsson, Bjarni A.
AU - Ahmed, Munaza
AU - Aittom, Kristiina
AU - Alducci, Elisa
AU - Andrulis, Irene L.
AU - Arason, Adalgeir
AU - Arnold, Norbert
AU - Artioli, Grazia
AU - Arver, Brita
AU - Auber, Bernd
AU - Azzollini, Jacopo
AU - Balmaña, Judith
AU - Barkardottir, Rosa B.
AU - Barnes, Daniel R.
AU - Barroso, Alicia
AU - Barrowdale, Daniel
AU - Belotti, Muriel
AU - Benitez, Javier
AU - Bertelsen, Brigitte
AU - Blok, Marinus J.
AU - Bodrogi, Istvan
AU - Bonadona, Valerie
AU - Bonanni, Bernardo
AU - Bondavalli, Davide
AU - Boonen, Susanne E.
AU - Borde, Julika
AU - Borg, Ake
AU - Bradbury, Angela R.
AU - Brady, Angela
AU - Brewer, Carole
AU - Brunet, Joan
AU - Buecher, Bruno
AU - Buys, Saundra S.
AU - Cabezas-Camarero, Santiago
AU - Caldes, Trinidad
AU - Caliebe, Almuth
AU - Caligo, Maria A.
AU - Calvello, Mariarosaria
AU - Campbell, Ian G.
AU - Carnevali, Ileana
AU - Carrasco, Estela
AU - Chan, Tsun L.
AU - Chu, Annie T.W.
AU - Chung, Wendy K.
AU - Claes, Kathleen B.M.
AU - Cook, Jackie
AU - Cortesi, Laura
AU - Couch, Fergus J.
AU - Daly, Mary B.
AU - Damante, Giuseppe
AU - Darder, Esther
AU - Davidson, Rosemarie
AU - De La Hoya, Miguel
AU - Della Puppa, Lara
AU - Dennis, Joe
AU - Díez, Orland
AU - Ding, Yuan Chun
AU - Ditsch, Nina
AU - Domchek, Susan M.
AU - Donaldson, Alan
AU - Dworniczak, Bernd
AU - Easton, Douglas F.
AU - Eccles, Diana M.
AU - Eeles, Rosalind A.
AU - Ehrencrona, Hans
AU - Ejlertsen, Bent
AU - Engel, Christoph
AU - Evans, D. Gareth
AU - Faivre, Laurence
AU - Faust, Ulrike
AU - Feliubadalo, Lídia
AU - Foretova, Lenka
AU - Fostira, Florentia
AU - Fountzilas, George
AU - Frost, Debra
AU - García-Barberan, Vanesa
AU - Garre, Pilar
AU - Gauthier-Villars, Marion
AU - Geczi, Lajos
AU - Gehrig, Andrea
AU - Gerdes, Anne Marie
AU - Gesta, Paul
AU - Giannini, Giuseppe
AU - Glendon, Gord
AU - Godwin, Andrew K.
AU - Goldgar, David E.
AU - Greene, Mark H.
AU - Gutierrez-Barrera, Angelica M.
AU - Hahnen, Eric
AU - Hamann, Ute
AU - Hauke, Jan
AU - Herold, Natalie
AU - Hogervorst, Frans B.L.
AU - Honisch, Ellen
AU - Hopper, John L.
AU - Hulick, Peter J.
AU - Izatt, Louise
AU - Jager, Agnes
AU - James, Paul
AU - Janavicius, Ramunas
AU - Jensen, Uffe Birk
AU - Jensen, Thomas Dyrso
AU - Johannsson, Oskar Th
AU - John, Esther M.
AU - Joseph, Vijai
AU - Kang, Eunyoung
AU - Kast, Karin
AU - Kiiski, Johanna I.
AU - Kim, Sung Won
AU - Kim, Zisun
AU - Ko, Kwang Pil
AU - Konstantopoulou, Irene
AU - Kramer, Gero
AU - Krogh, Lotte
AU - Kruse, Torben A.
AU - Kwong, Ava
AU - Larsen, Mirjam
AU - Lasset, Christine
AU - Lautrup, Charlotte
AU - Lazaro, Conxi
AU - Lee, Jihyoun
AU - Lee, Jong Won
AU - Lee, Min Hyuk
AU - Lemke, Johannes
AU - Lesueur, Fabienne
AU - Liljegren, Annelie
AU - Lindblom, Annika
AU - Llovet, Patricia
AU - Lopez-Fernandez, Adria
AU - Lopez-Perolio, Irene
AU - Lorca, Victor
AU - Loud, Jennifer T.
AU - Ma, Edmond S.K.
AU - Mai, Phuong L.
AU - Manoukian, Siranoush
AU - Mari, Veronique
AU - Martin, Lynn
AU - Matricardi, Laura
AU - Mebirouk, Noura
AU - Medici, Veronica
AU - Meijers-Heijboer, Hanne E.J.
AU - Meindl, Alfons
AU - Mensenkamp, Arjen R.
AU - Miller, Clare
AU - Gomes, Denise Molina
AU - Montagna, Marco
AU - Mooij, Thea M.
AU - Moserle, Lidia
AU - Mouret-Fourme, Emmanuelle
AU - Mulligan, Anna Marie
AU - Nathanson, Katherine L.
AU - Navratilova, Marie
AU - Nevanlinna, Heli
AU - Niederacher, Dieter
AU - Cilius Nielsen, Finn C.
AU - Nikitina-Zake, Liene
AU - Offit, Kenneth
AU - Olah, Edith
AU - Olopade, Olufunmilayo I.
AU - Ong, Kai Ren
AU - Osorio, Ana
AU - Ott, Claus Eric
AU - Palli, Domenico
AU - Park, Sue K.
AU - Parsons, Michael T.
AU - Pedersen, Inge Sokilde
AU - Peissel, Bernard
AU - Peixoto, Ana
AU - Perez-Segura, Pedro
AU - Peterlongo, Paolo
AU - Petersen, Annabeth Høgh
AU - Porteous, Mary E.
AU - Pujana, Miguel Angel
AU - Radice, Paolo
AU - Ramser, Juliane
AU - Rantala, Johanna
AU - Rashid, Muhammad U.
AU - Rhiem, Kerstin
AU - Rizzolo, Piera
AU - Robson, Mark E.
AU - Rookus, Matti A.
AU - Rossing, Caroline M.
AU - Ruddy, Kathryn J.
AU - Santos, Catarina
AU - Saule, Claire
AU - Scarpitta, Rosa
AU - Schmutzler, Rita K.
AU - Schuster, Hel
AU - Senter, Leigha
AU - Seynaeve, Caroline M.
AU - Shah, Payal D.
AU - Sharma, Priyanka
AU - Shin, Vivian Y.
AU - Silvestri, Valentina
AU - Simard, Jacques
AU - Singer, Christian F.
AU - Skytte, Anne Bine
AU - Snape, Katie
AU - Solano, Angela R.
AU - Soucy, Penny
AU - Southey, Melissa C.
AU - Spurdle, Amanda B.
AU - Steele, Linda
AU - Steinemann, Doris
AU - Stoppa-Lyonnet, Dominique
AU - Stradella, Agostina
AU - Sunde, Lone
AU - Sutter, Christian
AU - Tan, Yen Y.
AU - Teixeira, Manuel R.
AU - Teo, Soo Hwang
AU - Thomassen, Mads
AU - Tibiletti, Maria Grazia
AU - Tischkowitz, Marc
AU - Tognazzo, Silvia
AU - Toland, Amanda E.
AU - Tommasi, Stefania
AU - Torres, Diana
AU - Toss, Angela
AU - Trainer, Alison H.
AU - Tung, Nadine
AU - Van Asperen, Christi J.
AU - Van Der Baan, Frederieke H.
AU - Van Der Kolk, Lizet E.
AU - Van Der Luijt, Rob B.
AU - Van Hest, Liselotte P.
AU - Varesco, Liliana
AU - Varon-Mateeva, Raymonda
AU - Viel, Alessandra
AU - Vierstrate, Jeroen
AU - Villa, Roberta
AU - Von Wachenfeldt, Anna
AU - Wagner, Philipp
AU - Wang-Gohrke, Shan
AU - Wappenschmidt, Barbara
AU - Yoon, Sook Yee
AU - Wieme, Greet
AU - Yadav, Siddhartha
AU - Yannoukakos, Drakoulis
AU - Yoon, Sook Yee
AU - Zanzottera, Cristina
AU - Zorn, Kristin K.
AU - D’Amico, Anthony V.
AU - Freedman, Matthew L.
AU - Pomerantz, Mark M.
AU - Chenevix-Trench, Georgia
AU - Antoniou, Antonis C.
AU - Neuhausen, Susan L.
AU - Ottini, Laura
AU - Nielsen, Henriette Roed
AU - Rebbeck, Timothy R.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8þ) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 30 region of BRCA2 (c.7914þ) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001c.7913 [HR ¼ 1.78; 95% confidence interval (CI), 1.25–2.52; P ¼ 0.001], as well as elevated risk of Gleason 8þ prostate cancer (HR ¼ 3.11; 95% CI, 1.63–5.95; P ¼ 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR ¼ 2.83; 95% CI, 1.71–4.68; P ¼ 0.00004) and elevated risk of Gleason 8þ prostate cancer (HR ¼ 4.95; 95% CI, 2.12–11.54; P ¼ 0.0002). No genotype–phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer.
AB - Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8þ) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 30 region of BRCA2 (c.7914þ) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001c.7913 [HR ¼ 1.78; 95% confidence interval (CI), 1.25–2.52; P ¼ 0.001], as well as elevated risk of Gleason 8þ prostate cancer (HR ¼ 3.11; 95% CI, 1.63–5.95; P ¼ 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR ¼ 2.83; 95% CI, 1.71–4.68; P ¼ 0.00004) and elevated risk of Gleason 8þ prostate cancer (HR ¼ 4.95; 95% CI, 2.12–11.54; P ¼ 0.0002). No genotype–phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer.
UR - http://www.scopus.com/inward/record.url?scp=85079022145&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-19-1840
DO - 10.1158/0008-5472.CAN-19-1840
M3 - Article
C2 - 31723001
AN - SCOPUS:85079022145
SN - 0008-5472
VL - 80
SP - 624
EP - 638
JO - Cancer Research
JF - Cancer Research
IS - 3
ER -